{"product_id":"central-nervous-system-cns-biomarkers-technologies-and-global-markets","title":"Central Nervous System (CNS) Biomarkers: Technologies and Global Markets","description":"\u003cp\u003eCentral Nervous System (CNS) Biomarkers: Technologies and Global Markets\u003c\/p\u003e\n\n\u003cp\u003eReport Scope:\u003c\/p\u003e\n\n\u003cp\u003eThis study provides a comprehensive analysis of CNS biomarkers on a global basis. Its aim is to provide a range of information, from detailed product analyses within disease subsegments to overall industry trends, in order to quantify and qualify the global CNS biomarkers market.\u003c\/p\u003e\n\n\u003cp\u003eCurrent and projected product forecasts during the forecast period (2022 to 2027) are discussed. New products approved in 2021 and 2022 by the U.S. Food and Drug Administration (FDA), and those products expected to be approved within the forecast period are discussed. Market figures for 2022 are estimated, except where actual results have been reported.\u003c\/p\u003e\n\n\u003cp\u003eIncluded in this report are forecasts by biomarker type, technology type, disease, application, and region from 2022 through 2027. The report also includes analysis of leading and emerging competitors in the current worldwide CNS biomarkers market. Profiles of manufacturers of leading products as well as biotechnology companies with novel products in development are analyzed to define the specific product strategies employed. This report also assesses companies poised to introduce products during the forecast period and discusses how these introductions will change the face of the competitive environment. The competitive environment is examined with a special focus on how new products and technologies are influencing the current standard of care.\u003c\/p\u003e\n\n\u003cp\u003eReport Includes:\u003c\/p\u003e\n\n\u003cp\u003e43 tables\u003c\/p\u003e\n\n\u003cp\u003eAn overview of the global market and technologies for central nervous system (CNS) biomarkers\u003c\/p\u003e\n\n\u003cp\u003eEstimation of the market size and analyses of market trends, with data from 2019 to 2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027\u003c\/p\u003e\n\n\u003cp\u003eExplanation of market drivers, restraints and other forces impacting the global market\u003c\/p\u003e\n\n\u003cp\u003eDescription of technologies such as genomics, proteomics, and imaging, and assessments of their advantages and disadvantages.\u003c\/p\u003e\n\n\u003cp\u003eDiscussion of CNS disease segments, prevalence, and gaps in treatment for Alzheimer’s disease, depression, Parkinson’s disease, multiple sclerosis, and others\u003c\/p\u003e\n\n\u003cp\u003eCoverage of events like mergers \u0026amp; acquisitions, joint ventures, collaborations or partnerships, and other key market strategies\u003c\/p\u003e\n\n\u003cp\u003eComprehensive company profiles of major players of the industry, including Abbott, Bio-Rad Laboratories Inc., Eisai Co. Ltd., Merck and Thermo Fisher Scientific Inc.\u003c\/p\u003e\n\n\u003cp\u003eCompanies Mentioned\u003c\/p\u003e\n\n\u003cp\u003eABBOTT LABORATORIES LTD.\u003cbr\u003e\nBIO-RAD LABORATORIES INC.\u003cbr\u003e\nBIOMERIEUX S.A.\u003cbr\u003e\nC?N Diagnostics, LLC\u003cbr\u003e\nDiadem Spa\u003cbr\u003e\nEISAI CO. LTD.\u003cbr\u003e\nELI LILLY AND CO.\u003cbr\u003e\nF. Hoffmann-La Roche AG\u003cbr\u003e\nH.U. GROUP HOLDINGS INC.\u003cbr\u003e\nLABORATORY CORP. OF AMERICA (LABCORP)\u003cbr\u003e\nMERCK KGAA\u003cbr\u003e\nPERKINELMER INC.\u003cbr\u003e\nQUANTERIX CORP.\u003cbr\u003e\nQUEST DIAGNOSTICS INC.\u003cbr\u003e\nSHIMADZU CORP.\u003cbr\u003e\nSIEMENS HEALTHINEERS AG\u003cbr\u003e\nSYSMEX CORP.\u003cbr\u003e\nTHERMO FISHER SCIENTIFIC INC.\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"April, 2023 \/ 135 Pages \/ MCW16229580","offer_id":47646974116146,"sku":null,"price":6600.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/central-nervous-system-cns-biomarkers-technologies-and-global-markets","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}